Intended for healthcare professionals

  1. News & Views
  2. Covid-19: risk factors...
  3. Covid-19: risk factors for severe disease and death
Editorials

Covid-19: risk factors for severe disease and death

BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m1198 (Published 26 March 2020) Cite this as: BMJ 2020;368:m1198

Read our latest coverage of the coronavirus outbreak

Related articles

See more

Cited by...

  • SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
  • Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)
  • Effectiveness of inactive COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China
  • Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data
  • SafeFit Trial: virtual clinics to deliver a multimodal intervention to improve psychological and physical well-being in people with cancer. Protocol of a COVID-19 targeted non-randomised phase III trial
  • How do we fight COVID-19? Military medical actions in the war against the COVID-19 pandemic in France
  • Physical activity and the risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 related mortality in South Korea: a nationwide cohort study
  • A Chinese host genetic study discovered type I interferons and causality of cholesterol levels and WBC counts on COVID-19 severity
  • Dual roles of a novel oncolytic viral vector-based SARS-CoV-2 vaccine: preventing COVID-19 and treating tumor progression
  • Temporal association of reduced serum vitamin D with COVID-19 infection: A single-institution case-control and historical cohort study
  • Risk factors associated with severe outcomes of COVID-19: An updated rapid review to inform national guidance on vaccine prioritization in Canada
  • Job loss and lower healthcare utilisation due to COVID-19 among older adults across 27 European countries
  • COVID-19 health and social care access for autistic people: European policy review
  • Implications of COVID-19 infection on patients with uveitis under biologic treatment
  • A systematic review on Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Development of a scoring system for clinical diagnosis
  • Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis
  • Proteinuria and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Single-Center Study
  • Prognostic model to identify and quantify risk factors for mortality among hospitalised patients with COVID-19 in the USA
  • Return to sport for North American professional sport leagues in the context of COVID-19
  • Development and validation of a clinical and genetic model for predicting risk of severe COVID-19
  • Muscle strength is associated with COVID-19 hospitalization in adults 50 years of age or older
  • Pitfalls and solutions in case fatality risk estimation - A multi-country analysis on the role of demographics, surveillance, time lags between reporting and death and healthcare system capacity on COVID-19
  • The association between socioeconomic status and mobility reductions in the early stage of Englands COVID-19 epidemic
  • COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs
  • Covid-19 related deaths among doctors in India
  • Sleep apnoea is a risk factor for severe COVID-19
  • Risk factors for mortality among hospitalized patients with COVID-19
  • Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: A systematic review and meta-analysis
  • How urgent do intravitreal anti-VEGF injections need to be to justify the risk of transmitting COVID-19? Proof-of-concept calculations to determine the Health Adjusted Life-Year (HALY) trade-off
  • Seroprevalence of SARS-CoV-2 during pregnancy and associated outcomes: results from an ongoing prospective cohort study, New York City
  • Returning to a normal life via COVID-19 vaccines in the USA: a large-scale agent-based simulation study
  • Clinical, cerebrospinal fluid and neuroimaging findings in COVID-19 encephalopathy: a case series
  • Effect of park use and landscape structure on COVID-19 transmission rates
  • Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: a nationwide cohort study
  • Estimation of case-fatality rate in COVID-19 patients with hypertension and diabetes mellitus in the New York State
  • COVID-19 case-fatality rate and demographic and socioeconomic influencers: a worldwide spatial regression analysis based on country-level data
  • Association of country-wide coronavirus mortality with demographics, testing, lockdowns, and public wearing of masks (Update August 4, 2020)
  • SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
  • COVID-19 related mortality and spread of disease in long-term care: a living systematic review of emerging evidence
  • Prevalence and risks of severe events for cancer patients with COVID-19 infection: a systematic review and meta-analysis
  • Social Listening: A Thematic Analysis of COVID-19 Discussion on Social Media
  • Surveying Tenants of Permanent Supportive Housing in Skid Row about COVID-19
  • Sleep apnoea is a risk factor for severe COVID-19
  • Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19
  • Sensitive detection of SARS-CoV-2-specific-antibodies in dried blood spot samples
  • GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia
  • The support needs of Australian primary health care nurses during the COVID-19 pandemic
  • News from the front: Estimation of excess mortality and life expectancy in the major epicenters of the COVID-19 pandemic in Italy
  • First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe and Critical COVID-19 Pneumonia
  • Genomic Diversity of the SARS-CoV-2 in Turkey and the Impact of Virus Genome Mutations on Clinical Outcomes
  • Detecting space-time clusters of COVID-19 in Brazil: mortality, inequality, socioeconomic vulnerability, and the relative risk of the disease in Brazilian municipalities
  • Unraveling COVID-19-related hospital costs: The impact of clinical and demographic conditions
  • Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
  • Effects of Tocilizumab on Mortality in Hospitalized Patients with COVID-19: A Multicenter Cohort Study
  • COVID-19 :Determinants of Hospitalization, ICU and Death among 20,293 reported cases in Portugal
  • COVID-19: Impact of Obesity and Diabetes in Disease Severity
  • Development and external validation of a COVID-19 mortality risk prediction algorithm: a multicentre retrospective cohort study
  • Age, gender and COVID-19 infections
  • Trends of SARS-CoV-2 infection worldwide: Role of population density, age structure, and climate on transmission and case fatality
  • Risks to Children under-five in India from COVID-19
  • Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom
  • Erythrocytes Reveal Complement Activation in Patients with COVID-19
  • Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens
  • Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study
  • Multivariate Analysis of Factors Affecting COVID-19 Case and Death Rate in U.S. Counties: The Significant Effects of Black Race and Temperature
  • Early prediction of mortality risk among severe COVID-19 patients using machine learning
  • Burden and prevalence of prognostic factors for severe covid-19 disease in sweden
  • Factors associated with COVID-19 infections and mortality in Africa: a cross-sectional study using publicly available data
  • Epidemiology and transmission dynamics of COVID-19 in two Indian states
  • COVID-19 case-fatality rate and demographic and socioeconomic influencers: worldwide spatial regression analysis based on country-level data
  • Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
  • Background and concurrent factors predicting non-adherence to public health preventive measures during the chronic phase of the COVID-19 pandemic
  • SARS-CoV-2 seroprevalence and clinical features of COVID-19 in a German liver transplant recipient cohort: a prospective serosurvey study
Back to top